Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Senseonics Holdings, Inc.
< Previous
1
2
Next >
Senseonics Holdings, Inc. Reports Second Quarter 2024 Financial Results
August 08, 2024
From
Senseonics Holdings, Inc.
Via
Business Wire
Tickers
SENS
Senseonics Holdings, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for August 8, 2024 at 4:30 P.M. Eastern Time
July 25, 2024
From
Senseonics Holdings, Inc.
Via
Business Wire
Tickers
SENS
Senseonics Holdings, Inc. Provides Business Update and Full Year 2024 Financial Outlook
June 21, 2024
From
Senseonics Holdings, Inc.
Via
Business Wire
Tickers
SENS
Senseonics Holdings, Inc. to Host Business Update and Analyst Event During the American Diabetes Association’s 84th Scientific Sessions
June 13, 2024
From
Senseonics Holdings, Inc.
Via
Business Wire
Tickers
SENS
Senseonics Holdings, Inc. to Participate in the Sidoti Small Cap Conference
May 29, 2024
From
Senseonics Holdings, Inc.
Via
Business Wire
Tickers
SENS
Senseonics Holdings, Inc. Reports First Quarter 2024 Financial Results
May 13, 2024
From
Senseonics Holdings, Inc.
Via
Business Wire
Tickers
SENS
Senseonics and Mercy Collaborate to Improve Diabetes Population Health Management
May 13, 2024
From
Senseonics Holdings, Inc.
Via
Business Wire
Tickers
SENS
Senseonics Partners with Rimidi to Develop Innovative Diabetes Solution
May 09, 2024
From
Senseonics Holdings, Inc.
Via
Business Wire
Tickers
SENS
Senseonics Holdings, Inc. to Participate in Upcoming Conferences
May 02, 2024
From
Senseonics Holdings, Inc.
Via
Business Wire
Tickers
SENS
Senseonics Holdings, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 13, 2024 at 4:30 P.M. Eastern Time
April 30, 2024
From
Senseonics Holdings, Inc.
Via
Business Wire
Tickers
SENS
Eversense® CGM System Receives iCGM Designation by the US FDA
April 30, 2024
From
Senseonics Holdings, Inc.
Via
Business Wire
Tickers
SENS
Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes
March 08, 2024
From
Senseonics Holdings, Inc.
Via
Business Wire
Tickers
SENS
Senseonics Holdings, Inc. to Participate in the Oppenheimer 34th Annual Healthcare MedTech and Services Conference
March 06, 2024
From
Senseonics Holdings, Inc.
Via
Business Wire
Tickers
SENS
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
February 29, 2024
From
Senseonics Holdings, Inc.
Via
Business Wire
Tickers
SENS
Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 29, 2024 at 4:30 P.M. Eastern Time
February 15, 2024
From
Senseonics Holdings, Inc.
Via
Business Wire
Tickers
SENS
Medicare Coverage Significantly Expanded for the Eversense E3 CGM System
February 12, 2024
From
Senseonics Holdings, Inc.
Via
Business Wire
Tickers
SENS
Senseonics Holdings, Inc. Announces Business Updates
January 02, 2024
From
Senseonics Holdings, Inc.
Via
Business Wire
Tickers
SENS
Senseonics Holdings, Inc. Reports Third Quarter 2023 Financial Results
November 09, 2023
From
Senseonics Holdings, Inc.
Via
Business Wire
Tickers
SENS
Senseonics Holdings, Inc. to Participate in the Stifel 2023 Healthcare Conference
November 09, 2023
From
Senseonics Holdings, Inc.
Via
Business Wire
Tickers
SENS
Senseonics Holdings, Inc Schedules Third Quarter 2023 Earnings Release and Conference Call for November 9, 2023 at 4:30 p.m. Eastern Time
October 30, 2023
From
Senseonics Holdings, Inc.
Via
Business Wire
Tickers
SENS
Ascensia Diabetes Care and Senseonics Announce ‘The CGM for Real Life’ Campaign to Raise Awareness of How Long-Term Eversense E3 Empowers People with Diabetes
October 09, 2023
From
Senseonics Holdings, Inc.
Via
Business Wire
Tickers
SENS
Senseonics Announces the Last Patient Completion of the 365-Day ENHANCE Pivotal Clinical Study
September 26, 2023
From
Senseonics Holdings, Inc.
Via
Business Wire
Tickers
SENS
Senseonics Holdings, Inc. to Participate in the Gilmartin Group Emerging Growth Company Showcase
September 14, 2023
From
Senseonics Holdings, Inc.
Via
Business Wire
Tickers
SENS
Senseonics Holdings, Inc. Enters Into $50 Million Loan Facility With Hercules Capital
September 11, 2023
From
Senseonics Holdings, Inc.
Via
Business Wire
Tickers
SENS
Senseonics Holdings, Inc. Reports Second Quarter 2023 Financial Results
August 10, 2023
From
Senseonics Holdings, Inc.
Via
Business Wire
Tickers
SENS
Senseonics Holdings, Inc. Schedules Second Quarter 2023 Earnings Release and Conference Call for August 10, 2023 at 4:30 p.m. Eastern Time
July 27, 2023
From
Senseonics Holdings, Inc.
Via
Business Wire
Tickers
SENS
Senseonics Announces Equity Grants To Employees Under Inducement Plan
July 05, 2023
From
Senseonics Holdings, Inc.
Via
Business Wire
Tickers
SENS
New Clinical Data Demonstrating the Safety and Accuracy of Eversense through 365 Days Presented at the American Diabetes Association 83rd Scientific Sessions
June 26, 2023
From
Senseonics Holdings, Inc.
Via
Business Wire
Tickers
SENS
Senseonics Announces UnitedHealthcare Coverage of Eversense® E3 CGM for Adults with Diabetes
June 02, 2023
From
Senseonics Holdings, Inc.
Via
Business Wire
Tickers
SENS
Senseonics to Participate in the Jefferies Healthcare Conference
May 26, 2023
From
Senseonics Holdings, Inc.
Via
Business Wire
Tickers
SENS
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.